CA Patent

CA2371942A1 — Pseudomycin antifungal compositions and methods for their use

Assigned to Eli Lilly and Co · Expires 2000-10-26 · 26y expired

What this patent protects

Methods and compositions for treating fungal infections that include formulations of a pseudomycin or related antifungal agent and a cyclodextrin are described. The compositions are particularly useful in pharmaceutical applications to reduce adverse effects.

USPTO Abstract

Methods and compositions for treating fungal infections that include formulations of a pseudomycin or related antifungal agent and a cyclodextrin are described. The compositions are particularly useful in pharmaceutical applications to reduce adverse effects.

Drugs covered by this patent

Patent Metadata

Patent number
CA2371942A1
Jurisdiction
CA
Classification
Expires
2000-10-26
Drug substance claim
No
Drug product claim
No
Assignee
Eli Lilly and Co
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.